The tumor suppressor HNRNPK induces p53-dependent nucleolar stress to drive ribosomopathies

The nucleolus is a membraneless organelle and an excellent stress sensor. Any changes in its architecture or composition lead to nucleolar stress, resulting in cell cycle arrest and interruption of ribosomal activity, critical factors in aging and cancer. In this study, we identified and described the pivotal role of the RNA-binding protein HNRNPK in ribosome and nucleolar dynamics. We developed an in vitro model of endogenous HNRNPK overexpression and an in vivo mouse model of ubiquitous HNRNPK overexpression. These models showed disruptions in translation as the HNRNPK overexpression caused alterations in the nucleolar structure, resulting in p53-dependent nucleolar stress, cell cycle arrest, senescence, and bone marrow failure phenotype, similar to what is observed in patients with ribosomopathies. Together, our findings identify HNRNPK as a master regulator of ribosome biogenesis and nucleolar homeostasis through p53, providing what we believe to be a new perspective on the orchestration of nucleolar integrity, ribosome function and cellular senescence.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Investigation
Published
2025-05-08
DOI
https://doi.org/10.1172/jci183697
Citations
2
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
1.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The tumor suppressor HNRNPK induces p53-dependent nucleolar stress to drive ribosomopathies

Rosa García-Martín, Eduardo J. Caleiras, Marta Isasa, Marisa J.L. Aitken et al.
2 citations
Journal of Clinical Investigation
RNA modifications and cancer
1.61
article

The tumor suppressor HNRNPK induces p53-dependent nucleolar stress to drive ribosomopathies

Rosa García-Martín, Eduardo J. Caleiras, Marta Isasa, Marisa J.L. Aitken, Pedro Aguilar-Garrido, Oscar Benitez, Pilar Ximénez‐Embún, Vanesa Lafarga, Joaquín Martínez‐López, Gadea Mata, Prerna Malaney, Miguel Lafarga, Andrés Penagos‐Puig, Miguel Ángel Navarro-Aguadero, Josune Zubicaray, María Hernández‐Sánchez, Jesús Gómez, Alvaro Otero-Sobrino, Raúl Torres, Julián Sevilla, Diego Megı́as, Manuel Pérez‐Martínez, Sandra Rodríguez, María Velasco‐Estevez, Osvaldo Graña‐Castro, Marta Ibáñez-Navarro, Alejandra Ortiz-Ruiz, Enrique Revilla, Oleksandra Sirozh, Miguel Gallardo, Sean M. Post, Xiaorui Zhang, Orlando Domı́nguez, Ashley Rodriguez, Daniel Azorín, Miguel Ángel Marugal
article en
2 citations

Abstract

The nucleolus is a membraneless organelle and an excellent stress sensor. Any changes in its architecture or composition lead to nucleolar stress, resulting in cell cycle arrest and interruption of ribosomal activity, critical factors in aging and cancer. In this study, we identified and described the pivotal role of the RNA-binding protein HNRNPK in ribosome and nucleolar dynamics. We developed an in vitro model of endogenous HNRNPK overexpression and an in vivo mouse model of ubiquitous HNRNPK overexpression. These models showed disruptions in translation as the HNRNPK overexpression caused alterations in the nucleolar structure, resulting in p53-dependent nucleolar stress, cell cycle arrest, senescence, and bone marrow failure phenotype, similar to what is observed in patients with ribosomopathies. Together, our findings identify HNRNPK as a master regulator of ribosome biogenesis and nucleolar homeostasis through p53, providing what we believe to be a new perspective on the orchestration of nucleolar integrity, ribosome function and cellular senescence.

Journal of Clinical InvestigationVol. 135(12)
Dartmouth College (US), Universidad San Pablo CEU (ES), Universidad Complutense de Madrid (ES), Universidad de Cantabria (ES), The University of Texas MD Anderson Cancer Center (US), Research Institute Hospital 12 de Octubre (ES), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), Spanish National Cancer Research Centre (ES), Abterra Biosciences (United States) (US), Hospital Universitario 12 De Octubre (ES), Hospital Infantil Universitario Niño Jesús (ES), Instituto de Investigación Marqués de Valdecilla (ES), Centro de Investigación Biomédica en Red (ES), Dartmouth Psychiatric Research Center (US), Centro de Investigación del Cáncer (ES), Centro Nacional de Análisis Genómico (ES), Genomics (United Kingdom) (GB), HistoGenetics (United States) (US), Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (ES), Athens State University (US)
European Commission, Fundación Científica Asociación Española Contra el Cáncer, Fundación Española de Hematología y Hemoterapia, CRIS Cancer Foundation, Instituto de Salud Carlos III, European Regional Development Fund, HORIZON EUROPE Marie Sklodowska-Curie Actions
Openalex Percentile: Top 17%
RNA modifications and cancer
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.